Topical Wound Agents Market - Top Companies and Manufacturers

  • Report ID: 4569
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Topical Wound Agents Landscape

    • Smith & Nephew PLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Mölnlycke Health Care AB
    • Novartis Pharma AG
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Viatris Inc.
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Coloplast A/S
    • ConvaTec Limited

Browse Key Market Insights with Data Illustration:

In the News

  • Mölnlycke Health Care AB has announced the clinical results of its Mepilex Ag. This product has delivered effective results on a variety of wound types, including partial-thickness burns with low-to-medium exudate levels, thereby managing infection risks. Its soft silicone wound contact layer relieves wound and peri-wound pain caused by trauma and infection.

  • ConvaTec Limited has acquired Triad Life Sciences Inc. The Triad team, current portfolio, and product pipeline are projected to now exist as Convatec Advanced Tissue Technologies, under the Advanced Wound Care (AWC) brand.


Author Credits:  Radhika Pawar


  • Report ID: 4569
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of topical wound agents is assessed at USD 2.56 billion.

The topical wound agents market size was over USD 2.39 billion in 2024 and is projected to reach USD 7.15 billion by 2037, growing at around 8.8% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of chronic wounds, the increasing number of diabetic foot ulcers, the surge in burns cases, and the escalation in post-surgical wounds will drive the market growth.

North America industry is poised to account for largest revenue share of 40% by 2037, due to rising prevalence of chronic wounds and rising healthcare expenditure.

The major players in the market include Smith & Nephew PLC, Mölnlycke Health Care AB, Novartis Pharma AG, Pfizer Inc., Johnson & Johnson Services, Inc., Viatris Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Coloplast A/S, ConvaTec Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample